A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.
The best Bull and Bear pitches based on recency and number of recommendations.
Taking a bit of a flyer on this one given the leadership shuffling going on and questions surrounding some drugs in its pipeline. But despite the near-term challenges, Celgene is still producing more than $3.7 billion in FCF annually and is now… More
Celgene is a biopharmaceutical company focused on novel therapies to treat a broad range of hematopoietic, immunological, neuronal, and cancerous conditions. Celgene currently markets Thalomid for ENL and multiple myeloma, Revlimid for… More
Read the most recent pitches from players about CELG.DL.
Find the members with the highest scoring picks in CELG.DL.
See what the Wall Street professionals think, according to their public statements and filings.